TNFRSF6B and Autoimmunity: With this idea in view, the inventors of US20170051352 have developed a method for treating autoimmune conditions in patients carrying alterations of the gene encoding the DcR3 protein, or of a DcR3 network gene, by administering to said patient an effective amount of DcR3 ligands inhibitors [323].